Specificity of extended O-aryloxycarbonyl hydroxamates as inhibitors of a class C β-lactamase.

Bioorg Med Chem

Department of Chemistry, Wesleyan University, Middletown, CT 06459, USA. Electronic address:

Published: April 2019

Class C β-lactamases have previously been shown to be efficiently inactivated by O-aryloxycarbonyl hydroxamates. O-Phenoxycarbonyl-N-benzyloxycarbonylhydroxylamine (1) and O-phenoxycarbonyl-N-(R)-[(4-amino-4-carboxy-1-butyl)oxycarbonyl]hydroxylamine (2), for example, were found to be effective inactivators. The present paper describes a structure-activity study of these molecules to better define the important structural elements for high inhibitory activity. The results show that a well-positioned hydrophobic element (which may interact with the Tyr221 residue of the enzyme) and a negatively charged element, e.g. a carboxylate group (which may interact with Arg204), are required for high reactivity with the enzyme. The new compounds were found to inactivate by forming a carbonyl cross-linked enzyme (probably Ser64OCONHLys 315) as for 1 rather than the inert hydroxamoyl derivative observed with 2.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2019.02.023DOI Listing

Publication Analysis

Top Keywords

o-aryloxycarbonyl hydroxamates
8
specificity extended
4
extended o-aryloxycarbonyl
4
hydroxamates inhibitors
4
inhibitors class
4
class β-lactamase
4
β-lactamase class
4
class β-lactamases
4
β-lactamases efficiently
4
efficiently inactivated
4

Similar Publications

Hydroxamates as a potent skeleton for the development of metallo-β-lactamase inhibitors.

Chem Biol Drug Des

February 2022

Key Laboratory of Synthetic and Natural Functional Molecule of the Ministry of Education, College of Chemistry and Materials Science, Northwest University, Xi'an, China.

Bacterial resistance caused by metallo-β-lactamases (MβLs) has become an emerging public health threat, and the development of MβLs inhibitor is an effective way to overcome the resistance. In this study, thirteen novel O-aryloxycarbonyl hydroxamates were constructed and assayed against MβLs. The obtained molecules specifically inhibited imipenemase-1 (IMP-1) and New Delhi metallo-β-lactamase-1, exhibiting an IC value in the range of 0.

View Article and Find Full Text PDF

We use mass spectrometry (MS), under denaturing and non-denaturing solution conditions, along with ultraviolet photodissociation (UVPD) to characterize structural variations in New Delhi metallo-β-lactamase (NDM) upon perturbation by ligands or mutation. Mapping changes in the abundances and distributions of fragment ions enables sensitive detection of structural alterations throughout the protein. Binding of three covalent inhibitors was characterized: a pentafluorphenyl ester, an -aryloxycarbonyl hydroxamate, and ebselen.

View Article and Find Full Text PDF
Article Synopsis
  • The divergent structures and mechanisms of serine- and metallo-β-lactamases make it challenging to create broad-spectrum inhibitors that can effectively block both enzymes.
  • An unusual covalent inactivator, the O-aryloxycarbonyl hydroxamate, is shown to target specific residues in Enterobacter cloacae P99 serine-β-lactamase and can also label New Delhi metallo-β-lactamase-1 (NDM-1) at a key Lys residue.
  • The findings suggest that affinity labels targeting Lys residues could be a promising approach to develop drugs that inhibit both types of β-lactamases.
View Article and Find Full Text PDF

Specificity of extended O-aryloxycarbonyl hydroxamates as inhibitors of a class C β-lactamase.

Bioorg Med Chem

April 2019

Department of Chemistry, Wesleyan University, Middletown, CT 06459, USA. Electronic address:

Class C β-lactamases have previously been shown to be efficiently inactivated by O-aryloxycarbonyl hydroxamates. O-Phenoxycarbonyl-N-benzyloxycarbonylhydroxylamine (1) and O-phenoxycarbonyl-N-(R)-[(4-amino-4-carboxy-1-butyl)oxycarbonyl]hydroxylamine (2), for example, were found to be effective inactivators. The present paper describes a structure-activity study of these molecules to better define the important structural elements for high inhibitory activity.

View Article and Find Full Text PDF

Penicillin acylase and O-aryloxycarbonyl hydroxamates: Two acyl-enzymes, one leading to hydrolysis, the other to inactivation.

Arch Biochem Biophys

January 2017

Department of Chemistry, Wesleyan University, Middletown, CT 06459, USA. Electronic address:

O-Aryloxycarbonyl hydroxamates have previously been shown to covalently inactivate serine/amine amidohydrolases such as class C β-lactamases and a N-terminal hydrolase, the proteasome. We report here reactions between O-aryloxycarbonyl hydroxamates and another N-terminal hydrolase, penicillin acylase. O-Aryloxycarbonyl hydroxamates, as non-symmetric carbonates, have two different leaving groups attached to the reactive central carbonyl group.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!